Clinical Evalution of Nagaradi yoga in the management of Tamakaswasa w.s.r. to Bronchial Asthma

A CLINICAL EVALUATION OF NAGARADI YOGA IN THE MANAGEMENT OF TAMAKA SHWASA W.S.R. TO BRONCHIAL ASTHMA -AN OPEN LABELED SINGLE GROUP TRIAL - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/068827

Enrollment

Registered

2024-06-12

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma Health Condition 2: J984- Other disorders of lung

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with classical signs and symptoms of Tamaka Shwasa described inancient Ayurveda text will be selected for present study such as; ? ShwasaKrichchhata(Dyspnoea) ? Ghurghurukama(Wheezing sound) ? Kasa(Cough) ? Asamyakanidra(Disturbedsleep) ? Kantodhwamsa(Hoarseness of voice) ? Pinasa(Coryza) ? ShleshmaVimokshanteMuhurtam Sukham (After expectoration patient feelsbetter). ? ParshvaAvgrihyate(Chest tightness) ? Aasinolabhatesaukhyam (Comfortable in sitting position) 2.PEF: =50-100%

Exclusion criteria

Exclusion criteria: 1. Patient suffering from systemic or serious illness like Diabetes mellitus, Emphysema ,Renal disease and Cardiac diseases. 2. Patients of Cor pulmonale ,Cardiac asthma and severe exacerbation. 3. Any acute systemic disease or infection with post covid lung disease or complication. 4. Pregnant and lactating mothers. 5. Any malignancy. 6. Acute and serious conditions require immediate intervention will be excluded. 7. PEF less than 50%

Design outcomes

Primary

Measure	Time frame
Results will be assessed on the basis of gradation of clinical features of Tamaka ShwasaTimepoint: 2 weeks of completion of clinical trial or treatment	—

Secondary

Measure	Time frame
Peak flow meter reading to access improvement of lung functionsTimepoint: 2 weeks of completion of clinical trial or treatment	—

Countries

India

Contacts

Public ContactDr Anamika Soni

Government Akhandanand ayurveda college

ayursoni@yahoo.com9269533108

Outcome results